Head, Regulatory Affairs,
Asia Pacific Medical Association Ltd.
Anirudh joined APACMed as Country Lead for India in May 2020, with an objective of establishing the associations presence, brand, visibility, and engagement in country, and formulating and delivering the overall country strategy in alignment with APACMed regional strategy. His work includes leading APACMed India cross-functionally through Government Affairs, Market Access, Regulatory Affairs and Digital Health Centers of Excellence in India.Anirudh is also the Director, Regulatory Affairs APAC, where he is responsible for leading the regional regulatory affairs function through its market specific CoEs and regional working groups to drive the long-term vision, strategy and objectives of the Committee which is to improve patient access to medical devices across Asia Pacific. With nearly two decades of diversified work experience in both corporate and not–for–profit sectors, in the last decade he has been in leadership roles with a Regional Trade Association, National Association as well as an Apex Chamber of Commerce, where he designed, implemented, and led various strategic and tactical policy, regulatory and market access initiatives critical to business and industry. A creative and analytical thinker, with an inherent ability to develop rapport and credibility across audiences, Anirudh is well-networked with key government departments, trade associations and industry chambers, bi/multi-laterals, think tanks, non-profits and industry with deep understanding of the business, socio-economic, bureaucratic, and political landscape of India and Asia Pacific. Prior to joining APACMed, he was with the Federation of Indian Chambers of Commerce and Industry (FICCI) – the Apex Industry body in India where he was leading the Medical Devices, Health Insurance and Medical Value Travel sectors as Joint Director.'Anh Bourcet (Nguyen) is a global healthcare leader bringing over 12 years of experience in Asia-Pacific and Europe, in the public (French Safety Agency) and private sectors (Abbott, J&J). She is passionate about making an impact on patient care, by enabling change and better access to innovations. Her various roles in Medical Affairs, Health Economics & Market Access and Regulatory Policy, across diagnostics, medical devices and pharmaceutical industries, enable her to have a broad perspective on different levers of patient access.
Anh Bourcet is currently ASPAC Director, Market Access for Diagnostics in Abbott. In this role, Anh has been leading the Market Access & Policy Shaping strategy for Rapid Diagnostics, while establishing the function. She is Past-Chair of the Asia-Pacific Medical Technology Association Digital Health Committee Reimbursement Working Group, where she led the industry effort in shaping the external environment to drive access for Digital Health Technologies.
Data-driven, she has authored and reviewed many publications and spoken in various scientific and healthcare conferences to advance knowledge & collaboration.
Anh holds a PhD cum laude in Medicinal Chemistry from Paris VI & “Chimie ParisTech” Universities (France), and an Executive Master in Health Industry Management, ESSEC Business School (France).